stocks logo

BLRX Financial Analysis

BioLine RX Ltd
$
2.520
-0.130(-4.910%)

BLRX Financial Analysis

FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Total Revenue
4.94M
5.39M
6.86M
4.80M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Revenue from Goods & Services
4.94M
5.39M
6.86M
4.80M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Goods Sold
822.00K
897.00K
1.46M
3.69M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit
4.12M
4.50M
5.40M
1.11M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling General & Administrative Expenses
9.51M
-23.06%
10.27M
3.57%
10.22M
15.42%
12.97M
54.45%
12.36M
74.58%
9.92M
30.43%
8.86M
45.68%
8.40M
27.28%
7.08M
13.85%
7.60M
16.72%
6.08M
11.56%
6.60M
12.36%
6.22M
33.73%
6.51M
17.01%
5.45M
-20.34%
5.87M
-37.62%
4.65M
-30.02%
5.57M
-14.07%
6.84M
Research & Development Expense
2.57M
-5.94%
2.23M
-25.98%
2.49M
-32.30%
3.10M
-9.56%
2.73M
-37.58%
3.01M
-44.28%
3.68M
-16.93%
3.43M
-33.09%
4.37M
-11.25%
5.40M
4.98%
4.44M
3.67%
5.13M
10.78%
4.92M
41.30%
5.14M
10.75%
4.28M
-21.10%
4.63M
-43.48%
3.48M
-37.32%
4.64M
-12.49%
5.42M
Operating Profit
-5.39M
-56.41%
-5.77M
-41.78%
-4.82M
-45.55%
-11.86M
41.26%
-12.36M
74.58%
-9.92M
30.43%
-8.86M
45.68%
-8.40M
27.28%
-7.08M
13.85%
-7.60M
16.72%
-6.08M
11.56%
-6.60M
12.36%
-6.22M
33.73%
-6.51M
17.01%
-5.45M
-20.34%
-5.87M
-37.62%
-4.65M
-30.02%
-5.57M
-14.07%
-6.84M
Financing Income- Net
-1.19M
126.86%
-1.55M
72.80%
-364.00K
-6.67%
1.71M
-292.68%
-525.00K
232.28%
-897.00K
200.00%
-390.00K
227.73%
-888.00K
-1685.71%
-158.00K
-24.40%
-299.00K
166.96%
-119.00K
-34.62%
56.00K
-111.31%
-209.00K
-20.53%
-112.00K
-68.98%
-182.00K
-33.58%
-495.00K
-23.14%
-263.00K
-24.86%
-361.00K
34.20%
-274.00K
Interest Expense
1.19M
126.86%
1.55M
72.80%
364.00K
-6.67%
-1.71M
-292.68%
525.00K
232.28%
897.00K
200.00%
390.00K
227.73%
888.00K
-1685.71%
158.00K
-24.40%
299.00K
166.96%
119.00K
-34.62%
-56.00K
-111.31%
209.00K
-20.53%
112.00K
-68.98%
182.00K
-33.58%
495.00K
-23.14%
263.00K
-24.86%
361.00K
34.20%
274.00K
Other Non-Operating Income
756.00K
-124.07%
7.81M
-200.96%
4.49M
-253.98%
2.97M
-16.43%
-3.14M
-907.46%
-7.73M
-1788.43%
-2.92M
-329.97%
3.56M
58.85%
389.00K
-45.21%
458.00K
-311.06%
1.27M
-127.80%
2.24M
-139.81%
710.00K
141.50%
-217.00K
-74.26%
-4.56M
-1072.49%
-5.62M
-3074.07%
294.00K
-90.38%
-843.00K
-166.85%
469.00K
Income before Taxes
-5.82M
-63.66%
484.00K
-102.61%
-696.00K
-94.28%
-13.88M
142.26%
-16.02M
134.01%
-18.55M
149.16%
-12.16M
146.69%
-5.73M
33.16%
-6.85M
19.79%
-7.44M
8.78%
-4.93M
-51.63%
-4.30M
-64.10%
-5.72M
23.78%
-6.84M
1.06%
-10.19M
53.38%
-11.99M
21.48%
-4.62M
17.27%
-6.77M
23.43%
-6.65M
Net Income after Tax
-5.82M
-63.66%
484.00K
-102.61%
-696.00K
-94.28%
-13.88M
142.26%
-16.02M
134.01%
-18.55M
149.16%
-12.16M
146.69%
-5.73M
33.16%
-6.85M
19.79%
-7.44M
8.78%
-4.93M
-51.63%
-4.30M
-64.10%
-5.72M
23.78%
-6.84M
1.06%
-10.19M
53.38%
-11.99M
21.48%
-4.62M
17.27%
-6.77M
23.43%
-6.65M
Income Available to Common Shares
-5.82M
-63.66%
484.00K
-102.61%
-696.00K
-94.28%
-13.88M
142.26%
-16.02M
134.01%
-18.55M
149.16%
-12.16M
146.69%
-5.73M
33.16%
-6.85M
19.79%
-7.44M
8.78%
-4.93M
-51.63%
-4.30M
-64.10%
-5.72M
23.78%
-6.84M
1.06%
-10.19M
53.38%
-11.99M
21.48%
-4.62M
17.27%
-6.77M
23.43%
-6.65M
EPS - Basic
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-0.01
-0.00%
-0.02
100.00%
-0.02
100.00%
-0.01
-0.00%
-0.01
-0.00%
-0.01
-0.00%
-0.01
-0.00%
-0.01
-50.00%
-0.01
-75.00%
-0.01
-50.00%
-0.01
-66.67%
-0.02
-50.00%
-0.04
-33.33%
-0.02
-33.33%
-0.03
-25.00%
-0.04
EPS - Diluted
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-0.01
-0.00%
-0.02
100.00%
-0.02
100.00%
-0.01
-0.00%
-0.01
-0.00%
-0.01
-0.00%
-0.01
-0.00%
-0.01
-50.00%
-0.01
-75.00%
-0.01
-50.00%
-0.01
-66.67%
-0.02
-50.00%
-0.04
-33.33%
-0.02
-33.33%
-0.03
-25.00%
-0.04
EBIT
-5.39M
-56.41%
-5.77M
-41.78%
-4.82M
-45.55%
-11.86M
41.26%
-12.36M
74.58%
-9.92M
30.43%
-8.86M
45.68%
-8.40M
27.28%
-7.08M
13.85%
-7.60M
16.72%
-6.08M
11.56%
-6.60M
12.36%
-6.22M
33.73%
-6.51M
17.01%
-5.45M
-20.34%
-5.87M
-37.62%
-4.65M
-30.02%
-5.57M
-14.07%
-6.84M
EBITDA
-4.55M
-62.53%
-5.30M
-45.49%
-3.93M
-54.34%
-11.16M
35.88%
-12.14M
75.25%
-9.72M
30.24%
-8.60M
45.56%
-8.21M
27.82%
-6.93M
14.46%
-7.46M
17.81%
-5.91M
12.13%
-6.42M
13.20%
-6.05M
36.11%
-6.33M
18.29%
-5.27M
-19.21%
-5.68M
-37.91%
-4.45M
-30.71%
-5.35M
-14.35%
-6.52M
Depreciation Depletion & Amortization
840.00K
280.09%
476.00K
140.40%
897.00K
246.33%
706.00K
277.54%
221.00K
44.44%
198.00K
40.43%
259.00K
49.71%
187.00K
7.47%
153.00K
-8.38%
141.00K
-21.67%
173.00K
-4.95%
174.00K
-11.68%
167.00K
-18.14%
180.00K
-15.09%
182.00K
-43.30%
197.00K
-27.84%
204.00K
-10.53%
212.00K
-6.19%
321.00K

BLRX FAQs

What is BLRX's PE Ratio in 2025/4/4?

BLRX's PE ratio in April 4, 2025 is -344.33. This indicates the price investors are willing to pay for $1 of earnings.

What is BLRX's PS Ratio in 2025/4/4?

What is BLRX's Dividend Yield in 2024/Q3?

What is BLRX's Gross Margin in 2024/Q3?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is BLRX earnings result positive or negative?How should I trade on BLRX earnings?